{
    "nct_id": "NCT03384940",
    "official_title": "A Phase 2, Multicenter, Open-label Study of DS-8201a in Subjects With HER2-expressing Advanced Colorectal Cancer",
    "inclusion_criteria": "* Has pathologically documented unresectable, recurrent, or metastatic colorectal adenocarcinoma (until sponsor's notification to the study sites, subject must be a RAS/BRAF wild-type cancer)\n* Has received at least 2 prior regimens of standard treatment\n* Has measurable disease assessed by the investigator based on RECIST version 1.1.\n* Has an Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 1\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Has a medical history of myocardial infarction within 6 months, symptomatic congestive heart failure\n* Has a medical history of clinically significant lung disease\n* Has spinal cord compression or clinically active central nervous system metastases, defined as untreated and symptomatic, or requiring therapy",
    "miscellaneous_criteria": ""
}